Predict your next investment

Other
epibio.com/main.asp

See what CB Insights has to offer

Investments

1

About Epicentre Technologies Corporation

Epicentre is an enzyme manufacturer that specializes in life science kits.

Epicentre Technologies Corporation Headquarter Location

726 Post Road

Madison, Wisconsin, 53713-4620,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Epicentre Technologies Corporation News

Lucigen to Distribute Entire Epicentre Product Line

Apr 6, 2017

BMG LABTECH announces integration of entire product range with Genedata Screener Effective immediately, Lucigen Corporation will distribute the complete Epicentre product portfolio. Epicentre Technologies, known for its genomics and transcriptomics products for gene expression , cloning , and in vitro transcription, was acquired by Illumina in 2011. Lucigen manufactures and supplies products that advance research in the fields of synthetic biology, next generation sequencing, genetic amplification, and protein expression. “We are excited for Lucigen to expand its Epicentre product offerings,” said Mark Van Oene, Chief Commercial Officer for Illumina. “Lucigen has been a tremendous partner to Illumina and this agreement will continue to benefit scientists by delivering a full portfolio of great products.” “Illumina shares our commitment to serve scientists worldwide with high quality products that enable scientific breakthroughs. Providing a single-vendor solution gives life science professionals easy and seamless access to these products. The incorporation of products from the Epicentre portfolio, combined with Lucigen’s portfolio of genomics products, will help scientists accelerate and simplify their research,” stated Ralph Kauten, CEO of Lucigen. About Lucigen Lucigen Corporation is working to improve people’s lives by providing quality products and services to life science and healthcare professionals. Lucigen provides biomedical research products and services to customers worldwide, all under an ISO 13485 compliant quality system. To learn more, visit www.lucigen.com and follow @lucigen. View source version on businesswire.com: http://www.businesswire.com/news/home/20170406006138/en/ Lucigen Corporation

Epicentre Technologies Corporation Investments

1 Investments

Epicentre Technologies Corporation has made 1 investments. Their latest investment was in Alethia BioTherapeutics as part of their Series A on September 9, 2010.

CBI Logo

Epicentre Technologies Corporation Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/20/2010

Series A

Alethia BioTherapeutics

$9.3M

Yes

Date

9/20/2010

Round

Series A

Company

Alethia BioTherapeutics

Amount

$9.3M

New?

Yes

Co-Investors

Sources

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.